Dr. Mohamad Al Kateb, MD

Dr. Al Kateb practices at Albuquerque Ambulatory Eye Surgery Center (Harper Dr NE) in Albuquerque, New Mexico.

Dr. Al Kateb's NPI, 1275988180, was assigned on April 28, 2016. Dr. Al Kateb holds New Mexico license MD2021-1104.

Dr. Al Kateb's primary practice is Albuquerque Ambulatory Eye Surgery Center (Harper Dr NE), at 5901 Harper Dr Ne, Albuquerque, NM 87109. The practice phone is (505) 246-2622.

Dr. Al Kateb's primary practice is Albuquerque Ambulatory Eye Surgery Center (Harper Dr NE) in Albuquerque, New Mexico. Dr. Al Kateb is also affiliated with Presbyterian Hospital. The medical group on file is Sound Physicians. Dmand AI also links Dr. Al Kateb to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al Kateb practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Al Kateb's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Al Kateb's licenses on file in 2 states: New Mexico and Florida.

CMS data shows 782 Medicare services from Dr. Al Kateb across 6 procedure codes in 2024, for 206 Medicare patients. Medicare paid $63,869 for them.

CMS counts 206 Medicare patients who saw Dr. Al Kateb in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 44% are also on Medicaid. Their average risk score is 3.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al Kateb's median patient age at 62, with 40% women.

In 2024, Dr. Al Kateb wrote 518 Medicare Part D claims for 94 patients. 76% of them were for generic drugs. CMS names the drug for 383 of them, across 17 drugs with 11 or more claims each, at $317,918 in total drug cost. In 2023, CMS named 360 claims across 19 drugs.

Dr. Al Kateb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Al Kateb as offering telehealth.

CMS Open Payments shows 127 general payments to Dr. Al Kateb from 14 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 99% of the total. Gilead Sciences, Inc. paid the most, $598.